Document Type
Article
Publication Date
1-14-2023
Original Citation
Barendrecht S,
Schreurs A,
Geissler S,
Sabanov V,
Ilse V,
Rieckmann V,
Eichentopf R,
Künemund A,
Hietel B,
Wussow S,
Hoffmann K,
Körber-Ferl K,
Pandey R,
Carter GW,
Demuth H,
Holzer M,
Roßner S,
Schilling S,
Preuss C,
Balschun D,
Cynis H.
A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice. Alzheimers Res Ther. 2023;15(1):16.
Keywords
JMG, Mice, Humans, Animals, Amyloid beta-Peptides, Mice, Transgenic, Alzheimer Disease, tau Proteins, Amyloidosis, Brain, Disease Models, Animal, Amyloid beta-Protein Precursor
JAX Source
Alzheimers Res Ther. 2023;15(1):16.
ISSN
1758-9193
PMID
36641439
DOI
https://doi.org/10.1186/s13195-022-01144-y
Grant
Open Access funding enabled and organized by Projekt DEAL. This work was supported by the Alzheimer’s Association (grant: 2016‐NIRG‐396‐583) and National Institutes of Health (grant: U54 AG054345). The work in Leuven was supported by a research grant from FWO Flanders to DB (G0D76.14) and a scholarship from the Agency for Innovation by Science and Technology in Flanders (IWT) to AS (141698).
Abstract
BACKGROUND: Hyperphosphorylation and intraneuronal aggregation of the microtubule-associated protein tau is a major pathological hallmark of Alzheimer's disease (AD) brain. Of special interest is the effect of cerebral amyloid beta deposition, the second main hallmark of AD, on human tau pathology. Therefore, studying the influence of cerebral amyloidosis on human tau in a novel human tau knock-in (htau-KI) mouse model could help to reveal new details on their interplay.
METHODS: We studied the effects of a novel human htau-KI under fast-progressing amyloidosis in 5xFAD mice in terms of correlation of gene expression data with human brain regions, development of Alzheimer's-like pathology, synaptic transmission, and behavior.
RESULTS: The main findings are an interaction of human beta-amyloid and human tau in crossbred 5xFADxhtau-KI observed at transcriptional level and corroborated by electrophysiology and histopathology. The comparison of gene expression data of the 5xFADxhtau-KI mouse model to 5xFAD, control mice and to human AD patients revealed conspicuous changes in pathways related to mitochondria biology, extracellular matrix, and immune function. These changes were accompanied by plaque-associated MC1-positive pathological tau that required the htau-KI background. LTP deficits were noted in 5xFAD and htau-KI mice in contrast to signs of rescue in 5xFADxhtau-KI mice. Increased frequencies of miniature EPSCs and miniature IPSCs indicated an upregulated presynaptic function in 5xFADxhtau-KI.
CONCLUSION: In summary, the multiple interactions observed between knocked-in human tau and the 5xFAD-driven progressing amyloidosis have important implications for future model development in AD.
Comments
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.